Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment
PaperCitations, authors & open-access status
Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 7 citations, 2021 year and gold oa status.
7
Citations
2021
Year
gold
OA Status